We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IIPR:NYSEInnovative Industrial Properties, Inc. Analysis

Data as of 2026-04-10 - not real-time

$51.33

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

IIPR trades at $51.33, just below its 20‑day SMA of $51.37 and above the 50‑day SMA of $50.63, indicating a neutral price position. The stock offers a striking 15.2% dividend yield, but the payout ratio of 193% exceeds earnings, raising sustainability concerns. Valuation metrics show a trailing P/E of 13.1 versus an industry average of 32.8, and a price‑to‑book of 0.80, suggesting the market is pricing the REIT at a discount. The DCF model projects a fair value of $62.4, implying roughly 14% upside from the current price. Operating margins are robust at 51% and gross margin 88.6%, while revenue has contracted 13% year‑over‑year. However, free cash flow of $155.2 M supports dividend payments but net debt of $393 M dwarfs the $47.6 M cash balance.
Recent news confirms the board’s declaration of a $1.90 quarterly dividend, maintaining the 15% yield, and Compass Point upgraded its outlook to Neutral, though the price target remains modest at $45. The Q4 2025 FFO of $1.88 per share beat estimates, underscoring cash‑flow strength. Nonetheless, the high payout, declining revenue, and a 30% 30‑day volatility signal heightened risk. With a beta of 0.81 and a max drawdown of 24%, the stock is less volatile than the market but still vulnerable to sector headwinds. Overall, the combination of attractive yield, cheap valuation, and solid cash flow makes IIPR a potential upside play, provided investors monitor dividend sustainability and revenue trends.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • High dividend yield but unsustainable payout ratio
  • Neutral technical positioning near support
  • Recent earnings beat supports short‑term confidence

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF upside of ~14% and valuation discount to peers
  • Strong operating margins and cash flow generation
  • Growing demand for life‑science industrial space

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential dividend cuts if earnings do not improve
  • Revenue decline raises concern over long‑term growth
  • Sector tailwinds for biotech facilities support stability

Key Metrics & Analysis

REIT Metrics

P/FFO7.287026234030193

Technical Analysis

TrendNeutral
RSI51.3
Support$48.51
Resistance$54.10
MA 20$51.37
MA 50$50.63
MA 200$52.24
MACDBearish
VolumeStable
Fear & Greed Index87.45

Risk Assessment

Beta0.81
Volatility30.55%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.